Wednesday
04.15.2026
8:58 AM
Login form
Search
Calendar
«  March 2026  »
Su Mo Tu We Th Fr Sa
1234567
891011121314
15161718192021
22232425262728
293031
Entries archive

My site

Main » 2026 » March » 31

The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport.
Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping.
Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027.


(BUSINESS WIRE) -- The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping.

Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that elevates high-performance riders and horses to their rightful place on the world stage. Built on merit, integrity, and excellence, the PJL brings together the world’s be ... Read more »

Views: 42 | Added by: africa-live | Date: 03.31.2026 | Comments (0)

OSAKA, Japan & CAMBRIDGE, Mass. - Monday, 30. March 2026 AETOSWire Print About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified (BUSINESS WIRE) -- Takeda (TSE:4502/NYSE:TAK) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost cle ... Read more »

Views: 49 | Added by: africanewsline | Date: 03.31.2026 | Comments (0)

~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~

... Read more »

Views: 63 | Added by: africa-live | Date: 03.31.2026 | Comments (0)